Health‐care practitioner use of prescription drug monitoring programs in clinical practice in Australia: A qualitative study

Abstract

IntroductionPrescription drug monitoring programs (PDMP) are electronic databases used by prescribers and pharmacists to monitor the use of high‐risk prescription medications subject to extramedical use. This study aimed to explore how Australian pharmacists and prescribers are using PDMPs in practice and to gain an understanding of barriers to tool use, as well as practitioner recommendations to increase tool usability and uptake.MethodsSemi‐structured interviews were conducted with pharmacists and prescribers who use a PDMP (n = 21). The interviews were audio‐recorded, transcribed and thematically analysed.ResultsThe four themes that emerged were: (i) PDMP notifications combined with practitioner clinical judgement guide PDMP usability; (ii) practitioners use PDMPs to facilitate patient and practitioner communication; (iii) workflow systems integration impacts tool usability; and (iv) optimising PDMP information and data access including practitioner‐tool engagement to improve tool uptake and usability.Discussion and ConclusionsPractitioners appreciate the value of PDMP information support for clinical decisions and patient communication. However, they also acknowledge the challenges to tool use and recommend improvements including enhanced workflow, systems integration, optimisation of tool information and national data sharing. Practitioners provide an important perspective on PDMP use in clinical practice. The findings can be drawn on by PDMP administrators to improve tool usefulness. Consequently, this may lead to an increase in practitioner PDMP use and optimise the delivery of quality patient care.